Summit Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Summit Wealth Partners's AMGN Position: Q1 2026 in Review
Summit Wealth Partners increased its Amgen (AMGN) stake by 48% in Q1 2026, buying an estimated $159K and bringing the position to 1,372 shares worth $483K. The position accounts for 0.08% of the portfolio, ranked #167.
Summit Wealth Partners first reported a position in AMGN in Q2 2020 and has held it in 21 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Summit Wealth Partners held 1,372 shares of Amgen worth $483K as of Q1 2026.
- Summit Wealth Partners bought 446 Amgen shares in Q1 2026, an estimated $159K.
- Amgen made up 0.08% of Summit Wealth Partners's portfolio in Q1 2026, its #167 holding.
- Summit Wealth Partners first reported a position in Amgen in Q2 2020 and has held it in 21 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Summit Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.